 BOSTON--BUSINESS WIRE--Therapeutics Acquisition Corp, dba Research Alliance Corp. I, a Delaware corporation the Company Nasdaq: RACA announced today that its registration statement on Form S-4 File Number 333-254600 as amended, the Registration Statement, relating to the previously announced business combination the Business Combination with POINT Biopharma Inc. POINT, has been declared effective by the U.S. Securities and Exchange Commission SEC and that it will com 